loader image
Friday, November 28, 2025
71.2 F
McAllen
- Advertisement -

Switching To A Healthier Diet Linked To Improved Longevity

Translate to Spanish or other 102 languages!

More emerging evidence suggests that improving one’s diet could help prolong a person’s life. Image for illustration purposes.
- Advertisement -
  • Fewer than 0.1% of adults in the United Kingdom adhere to the U.K. Government’s Eatwell Guide for a healthy, balanced diet.
  • Adults could add nearly 9 years of life expectancy by switching from an unhealthy diet to the diet outlined in the U.K.’s Eatwell Guide, a U.K. Biobank study has shown. 
  • Those who already follow the ‘median’ diet in the U.K., which only partially follows the Eatwell Guide recommendations, could gain around 3 years in life expectancy by making the full switch to a healthier diet. 
  • The study authors are calling for long-term action to be taken to enable more adults to eat healthily in order to reduce the burden of disease from poor diet. 

Poor diet and lack of physical activity are “leading global risks to health,” according to the World Health Organization (WHO)Trusted Source.

Follow the link below to read the full article on Medical News Today;

https://www.medicalnewstoday.com/articles/switching-to-a-healthier-diet-linked-to-improved-longevity

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.

Can Your Driving Patterns Predict Cognitive Decline?

Using in-vehicle driving data may be a new way to identify people who are at risk of cognitive decline, according to a study published on November 26, 2025, in Neurology®, the medical journal of the American Academy of Neurology.
- Advertisement -
×